Related Experiment Video
Updated: Apr 16, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
CCR 20th anniversary commentary: BMS-247550—microtubule stabilization as successful targeted therapy
Navjotsingh Pabla1, Alex Sparreboom2
1Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee.
Abstract:
In a landmark article published in the May 1, 2001, issue of Clinical Cancer Research, Lee and colleagues reported the original preclinical studies demonstrating anticancer activity of BMS-247550 (ixabepilone) against taxane-sensitive and taxane-resistant cancers. Subsequent clinical trials established the clinical efficacy of ixabepilone, leading to its regulatory approval for the treatment of drug-resistant metastatic or locally advanced breast cancers.
Insights
Ixabepilone demonstrated anticancer activity in preclinical studies and clinical trials. This led to its approval for treating advanced, drug-resistant breast cancers.
Area of Science:
- Oncology
- Pharmacology
Background:
- BMS-247550 (ixabepilone) exhibits anticancer properties.
- Preclinical studies showed efficacy against taxane-sensitive and resistant cancers.
Purpose of the Study:
- To summarize the development and approval of ixabepilone.
- To highlight its role in treating resistant breast cancers.
Main Methods:
- Review of preclinical studies on BMS-247550.
- Analysis of subsequent clinical trials evaluating ixabepilone efficacy.
Main Results:
- Demonstrated anticancer activity in preclinical models.
- Established clinical efficacy in patients with resistant breast cancers.
Conclusions:
- Ixabepilone is an effective treatment for drug-resistant metastatic or locally advanced breast cancers.
- Regulatory approval signifies its clinical importance.
More Related Videos
08:13Spatiotemporal Subcellular Manipulation of the Microtubule Cytoskeleton in the Living Preimplantation Mouse Embryo using Photostatins
Published on: November 30, 2021
10:44Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
Related Concept Videos
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Destabilization of Microtubules
Microtubule Instability
Microtubule Instability
Targeted Cancer Therapies
There are several types of targeted therapies against...